Pancreatic Cancer Research

ResearcherPeking University First HospitalActive in the last 2 years

Huahu Guo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5030498141. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 10

  1. Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. Co-author DOI 10.21037/jgo-23-985↗
  2. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression. Co-author DOI 10.1016/j.ebiom.2021.103315↗
  3. Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2/PI3K/AKT axis. First author DOI 10.21037/atm-20-2194↗
  4. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway. First author DOI 10.1016/j.canlet.2020.06.009↗
  5. High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN. Co-author DOI 10.1016/j.yexcr.2020.112088↗
  6. BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis. Co-author DOI 10.1016/j.canlet.2019.02.031↗
  7. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer. Co-author DOI 10.3892/or.2018.6178↗
  8. Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/jca.21347↗
  9. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling. Co-author DOI 10.1016/j.canlet.2017.05.006↗
  10. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.bbrc.2016.09.099↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yinmo Yang · 6 shared papers, 2017–2021 · strength 0.59
  2. Xiaodong Tian · 5 shared papers, 2017–2020 · strength 0.49
  3. Zhengkui Zhang · 5 shared papers, 2017–2021 · strength 0.46
  4. Feng Wang · 5 shared papers, 2017–2021 · strength 0.45
  5. Marko Kornmann · 5 shared papers, 2017–2020 · strength 0.43
  6. Xiaodong Tian · 3 shared papers, 2018–2021 · strength 0.37
  7. Chong Du · 4 shared papers, 2017–2019 · strength 0.31
  8. Ling Ma · 4 shared papers, 2017–2019 · strength 0.31
  9. Yazhou Wang · 2 shared papers, 2020–2021 · strength 0.29
  10. Mingzhe Li · 2 shared papers, 2020–2021 · strength 0.27
  11. Kai Chen · 2 shared papers, 2020–2021 · strength 0.27
  12. Zhiqiang Gao · 1 shared paper, 2024 · strength 0.21
  13. Shishi Qiao · 1 shared paper, 2024 · strength 0.21
  14. Huayu Yang · 1 shared paper, 2024 · strength 0.21
  15. Penglei Ge · 1 shared paper, 2024 · strength 0.21
  16. Yang Wu · 1 shared paper, 2024 · strength 0.21
  17. Yazhou Wang · 2 shared papers, 2016–2019 · strength 0.15
  18. Yinmo Yang · 1 shared paper, 2021 · strength 0.14
  19. Weikang Liu · 1 shared paper, 2021 · strength 0.14
  20. Yinmo Yang · 1 shared paper, 2020 · strength 0.13
  21. Xiaoran Liu · 1 shared paper, 2017 · strength 0.07
  22. Xi-sheng Leng · 1 shared paper, 2016 · strength 0.07
  23. Weihua Zhu · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.